OneMedNet Corp

Name: OneMedNet Corp standardized financial statements, quarterly
Creator: Listed

ONMDNasdaqCIK 1849380IndustrialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$292.0k, Q2 FY2026

Operating income−$2.3m, Q2 FY2026

Net income−$2.2m, Q2 FY2026

OneMedNet Corp, income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	0.3	0.3	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.9	0.1	0.3
Cost of revenue	$m	0.3	0.3	0.3	0.3	0.2	0.1	0.4	0.4	0.4	0.7	0.5	0.9
Gross profit	$m	0.0	0.0	(0.1)	(0.1)	(0.1)	(0.0)	(0.2)	(0.2)	(0.2)	0.2	(0.4)	(0.6)
Research and development	$m	0.4	0.5	0.4	0.4	0.3	0.3	0.3	0.4	0.3	0.4	0.3	0.3
Operating income	$m	(1.9)	(1.9)	(2.1)	(2.5)	(2.3)	(2.7)	(2.2)	(2.1)	(2.2)	(3.1)	(2.6)	(2.3)
Interest expense	$m	not reported	(0.5)	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
Income tax	$m	0.1	(0.2)	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Net income	$m	(13.8)	(2.5)	(2.1)	(3.6)	(2.1)	(2.4)	(1.9)	3.0	(0.7)	(3.1)	(2.5)	(2.2)
Diluted EPS	$ per share	(3.23)	not reported	(0.08)	(0.14)	(0.07)	not reported	(0.06)	0.07	(0.01)	not reported	(0.04)	(0.04)
Basic EPS	$ per share	(3.23)	not reported	(0.08)	(0.14)	(0.07)	not reported	(0.06)	0.07	(0.01)	not reported	(0.04)	(0.04)

Balance sheet

Cash and equivalents$358.0k, Q2 FY2026

Long-term debt$132.0k, Q2 FY2026

Shareholders' equity−$3.5m, Q2 FY2026

OneMedNet Corp, balance sheet, quarterly
Line item	Unit	period not labelled2023-12-21	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	period not labelled2026-04-30	Q2 FY20262026-06-30
Cash and equivalents	$m	0.0	0.2	0.4	1.9	0.2	0.1	0.1	0.1	0.6	0.2	not reported	0.4
Current assets	$m	0.4	0.7	1.0	4.3	3.6	1.6	2.3	1.4	2.1	1.5	not reported	1.3
Total assets	$m	0.5	0.8	1.0	4.4	3.7	1.7	2.3	1.5	2.2	1.5	not reported	1.4
Current liabilities	$m	13.8	14.7	20.0	18.6	19.2	18.2	6.2	5.0	4.8	5.4	not reported	4.7
Total liabilities	$m	13.9	16.5	20.2	18.7	19.7	18.3	6.2	5.4	5.1	5.6	not reported	4.9
Long-term debt	$m	0.5	not reported	2.4	2.3	2.3	2.3	not reported	not reported	0.2	0.2	not reported	0.1
Current portion of debt	$m	not reported	not reported	not reported	not reported	9.4	not reported	not reported	not reported	1.0	0.8	not reported	0.7
Short-term borrowings	$m	0.5	not reported	not reported	2.3	2.3	2.3	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	(13.4)	(15.7)	(19.2)	(14.3)	(16.0)	(16.6)	(3.8)	(3.9)	(3.0)	(4.1)	0.2	(3.5)

Cash flow

Operating cash flow−$1.9m, Q2 FY2026

Capital expenditure$9.0k, Q2 FY2026

OneMedNet Corp, cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(1,100)	(1,725)	(1,547)	(1,506)	(1,903)	(1,996)	(1,854)	(2,189)	(1,747)	(1,713)	(1,542)	(1,875)
Capital expenditure	$k	21.0	16.0	6.0	1.0	9.0	35.0	5.0	3.0	0.0	5.0	2.0	9.0

Diluted shares (weighted)58.02m, Q2 FY2026

OneMedNet Corp, shares, quarterly
Line item	Unit	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	4.0	4.0	4.3	24.9	25.2	29.3	34.1	38.4	52.6	55.3	58.0

Shares outstanding: 59.29m at Aug 11, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.